Saturday, July 4, 2026

Unlocking Cancer Treatment: Samsung Bioepis Achieves Keytruda Biosimilar Equivalence in Global Trials

Samsung Bioepis' biosimilar SB27 shows equivalence to Keytruda in key clinical trials, enhancing access to cancer immunotherapy.

LG CNS Partners with Palantir: How This AI Collaboration Will Transform the Asian Market

LG CNS partners with Palantir to enhance AI transformation, focusing on tailored solutions across various sectors for improved decision-making.

NewJeans’ Parents Speak Out on Instagram Amid Agency Dispute, Share Struggles with Media

The parents of NewJeans take to Instagram to share their side of the dispute with HYBE, addressing misrepresentation concerns.

Tag: Myeongdong Cathedral

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.